{"id":5903,"date":"2013-07-11T22:15:13","date_gmt":"2013-07-11T22:15:13","guid":{"rendered":"http:\/\/www.pixelube.com\/work\/c4c\/?page_id=5903"},"modified":"2014-06-24T23:42:06","modified_gmt":"2014-06-24T23:42:06","slug":"entrepreneurs-in-residence","status":"publish","type":"page","link":"https:\/\/www.pixelube.com\/work\/c4c\/for-researchers\/entrepreneurs-in-residence\/","title":{"rendered":"Entrepreneurs-In-Residence"},"content":{"rendered":"

 <\/p>\n

New Ventures Advisors Lend Their Expertise<\/h1>\n

C4C\u2019s New Ventures team has created a vibrant network of expert advisors, including entrepreneurs, business executives, angel and venture capital investors, attorneys and others. This network is an invaluable resource for UW researchers as they are developing their business ideas.<\/p>\n

Our highly effective Entrepreneurs-in-Residence (EIR)<\/a> program invites veteran industry experts to join C4C for six to nine months at a time. During this period, they help identify technologies with commercial promise, and provide UW researchers with real-world insights about the commercialization process along with expertise in target markets, product development, and fundraising strategies. See current EIRs below.<\/a><\/p>\n

Our new Capitalization Table Board of Advisors<\/a> program will help UW start-up companies ensure that the structure of the start-up is appropriate for the business model and plan for the company. And it will help ensure the company is fundable and operational moving forward. See current advisors below.<\/a><\/p>\n

<\/a><\/p>\n

Current C4C EIRS<\/h2>\n
\n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tRhonda Rhyne<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tCraig W. Philips<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tSteve Dimmer<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tTom Dawson<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tDavid Bluhm<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tRobert Barry<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tRob Arnold<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t <\/div>\n

Emeritus EIRs:<\/h2>\n
Stephanie Amoss<\/strong>, healthcare and medical device consultant
\nWilliam R. Baker<\/strong>, senior pharmaceutical executive at Gilead Sciences
\nHenry Berg<\/strong>, engineering executive and former director at A3 Alliance, LLC
\nRonald Berenson<\/strong>, medical oncologist who founded biotechnology companies HemaQuest Pharmaceuticals, Xcyte, and CellPro
\nGino Borland<\/strong>, serial entrepreneur and energy angel investor
\nTerri Butler<\/strong>, technology entrepreneur, former product developer at 3M Company
\nJeff Canin<\/strong>, energy angel investor, former venture capitalist, investment banker, and wall street analyst and co-founder of three energy related companies
\nTom Clement<\/strong>, co-founder and former CEO of Pathway Medical Technologies and board chairman of the WBBA
\nDavid Croniser<\/strong>, former pioneer of diagnostic imaging at Siemens
\nMichael Cockrill<\/strong>, managing partner of Atlas Accelerator and former CTO of QPass
\nPerry Fell<\/strong>, board chairman and former CEO of NanoString Technologies and co-founder of Seattle Genetics<\/div>\n
Lars Johansson<\/strong>, an active Cleantech angel investor and the co-chair of Northwest Energy Angels<\/span><\/div>\n
Alex St. John<\/strong>, founder of Wild Tangent and former Microsoft gaming evangelist<\/span><\/div>\n
David Kaplan<\/strong>, electric vehicle entrepreneur previously at GridPoint<\/span><\/div>\n
Deborah Kessler<\/strong>, former senior executive at Acucela and Rosetta Inpharmatics<\/span><\/div>\n
Michael \u201cLuni\u201d Libes<\/strong>,\u00a0<\/span>serial entrepreneur and advisor to early-stage companies<\/span><\/div>\n
Richard Mander<\/strong>, former executive at Apple, Human Ware, and Big Screen Live<\/span><\/div>\n
Ken Myer<\/strong>, former CEO of the WTIA, co-founder of Interval Systems, and executive at Active Voice Corp and IBM<\/span><\/div>\n
Thomas Schulte<\/strong>, veteran of medical device research and development at Becton Dickinson & Co.<\/span><\/div>\n
Ted Weiler<\/strong>, a veteran of R&D and marketing of medical devices at ATL (Phillips), Physio-Control, and Olympic Medical (Natus)<\/span><\/div>\n
Bob Wilcox<\/strong>, former senior biomedical executive at EKOS and LifeSpex<\/span><\/div>\n
Chris Wood<\/strong>, a 25-year veteran in medical image post-processing and former executive at Picker International and Siemens Medical Solutions and co-founder at Confirma<\/span><\/div>\n
<\/span>\"eir\"It\u2019s motivating that such talented and experienced executives are choosing to devote their time to identifying opportunity at our university.<\/p>\n

Linden Rhoads<\/strong>
\nUW Vice Provost\u2014Commercialization<\/div>\n

\n

Commercialization Board of Advisors<\/h2>\n
\n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\tMedical Devices Co-Chair

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tWayne C. Wager<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\tMedical Devices Co-Chair

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tTrevor Moody<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\tTherapeutics & Diagnostics Co-Chair

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tCarol Gallagher<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\tTherapeutics & Diagnostics Co-Chair

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tMichael Gallatin<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\tCommercialization Board Overall Chair

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tAlan Frazier<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t <\/div>\n
\n

<\/a><\/p>\n

Capitalization Table Board of Advisors<\/h2>\n

The capitalization table board of advisors is offered as an opt-in resource to UW start-up companies. C4C has recruited a panel of top venture attorneys and other veterans representing the different roles in the innovation ecosystem to informally counsel founders on their initial decisions around allocation of equity in their start-up. These advisors are experts on best practice, current market norms, and deal terms.<\/p>\n

Decisions on equity allocation and capitalization structure need to be appropriate for the start-up\u2019s business model. They must be made such that the resultant company is fundable and will have the best opportunity to execute on its plan. Issues with the capitalization table can cause serious problems for start-ups when decisions were made without the benefit of conferring on best practice.<\/p>\n

The C4C New Ventures group helps to prepare each team that presents to the board by providing foundational materials on capitalization table construction, coaching on advance preparation of a presentation on the contributions of founders to date, and the expected and needed contributions from founders, advisors, consultants, start-up management, and employees going forward. The format of each meeting is an open dialogue between the start-up team and the board of advisors.
\n

\n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tScott Jacobson<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tDavid Bluhm<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tPatrick Stayton<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tVikram Jandhyala<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tJoe Wallin<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tSonya Erickson<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tCraig Sherman<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t \n\t \n\t
\n\t\t
\n\t\t\n\t\t\t
\n\t\t\t\t

\n\t\t\t\tREAD FULL BIO »<\/span><\/a><\/span>\n\t\t\t<\/div>\n\t\t<\/a>\n\t\t<\/div>\n\t\t\n\t\t
\n\t\tDavid Clarke<\/a>\n\t\t<\/div>\n\t\t<\/div>\n\t \n\t <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"

  New Ventures Advisors Lend Their Expertise C4C\u2019s New Ventures team has created a vibrant network of expert advisors, including entrepreneurs, business executives, angel and venture capital investors, attorneys and […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7,"menu_order":9,"comment_status":"open","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-5903","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/pages\/5903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/comments?post=5903"}],"version-history":[{"count":1,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/pages\/5903\/revisions"}],"predecessor-version":[{"id":6151,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/pages\/5903\/revisions\/6151"}],"up":[{"embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/pages\/7"}],"wp:attachment":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/media?parent=5903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}